This panel brings together expertise from Dark Horse Consulting and Converge Consulting spanning CMC, MS&T, supply chain, and commercial launch to explore key considerations to account for when preparing for commercialization of advanced therapeutics. Panelists will share practical insights on accelerating timelines, scaling complex manufacturing processes, managing supply chain risk, and aligning technical strategy with commercial readiness. Through real-world examples and cross-functional perspectives, the discussion will highlight critical success factors from early development through launch. Attendees will gain actionable strategies to navigate regulatory expectations, ensure quality, and build resilient operations that support growth in an increasingly competitive and dynamic market.